Economic Burden of Musculoskeletal Diseases in Canada Presented by Sylvie Desjardins, Policy Research Unit, Public Health Agency of Canada October 23 rd, 2006 1
Fact Sheet MSK has the higher prevalence of all chronic diseases; MSK disorders are increasing as our population ages; MSK in Quebec is less prevalent; MSK conditions are in the top ten leading causes of YLD s in Canada, 2003 Prevalence of specific MSK conditions Canada 2001 5 45% 4 35% Arthritis/Rheumatism Fibromyalgia Back problem 3 25% 2 15% 1 5% 15-34 35-54 55-64 65-74 75+ Age Group Source: CCHS 2001 2
Prevalence of specific MSK conditions Québec 2001 4 35% 3 25% Arthritis/Rheumatism Fibromyalgia Back problem 2 15% 1 5% 15-34 35-54 55-64 65-74 75+ Age Group Source: CCHS 2001 Prevalence of specific MSK conditions Canada 2005 6 5 4 Arthritis/Rheumatism Fibromyalgia Back problem 3 2 1 15-34 35-54 55-64 65-74 75+ Age Group Source: CCHS 2005 3
Prevalence of specific MSK conditions Québec 2005 5 45% 4 35% 3 25% 2 15% 1 5% Arthritis/Rheumatism Fibromyalgia Back problem 15-34 35-54 55-64 65-74 75+ Age Group Source: CCHS 2005 Prevalence of specific MSK conditions, by sex, Canada 2005 Male Female 12% 12% 24% 8% 9% 19% 52% 64% Rheumatoid Arthritis Osteoarthritis Rheumatism Others Source: CCHS 2005 4
Prevalence of Arthritis or Rheumatism by age, Canada 2005 6 5 4 3 2 1 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80+ Source: CCHS 2005 Age Group Prevalence of Arthritis or Rheumatism by age and sex, Canada 2005 6 5 4 Male Female 3 2 1 Source: CCHS 2005 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 Age Group 60-64 65-69 70-74 75-79 80+ 5
Prevalence of Arthritis or Rheumatism by province, Canada 2005 25% 2 15% 1 5% NFLD, LAB. Source: CCHS 2005 P.E.I. Nova Scotia New Brunswick Quebec Ontario Manitoba Saskatchewan Alberta British Columbia Prevalence of Rheumatoid Arthritis, Canada 2005 5% 4% 3% 2% 1% NFLD, LAB. Source: CCHS 2005 P.E.I. Nova Scotia New Brunswick Quebec Ontario Manitoba Saskatchewan Alberta British Columbia 6
Ten major diseases reducing functioning, Canada 2002 Unipolar depressive disorders Diabetes mellitus Hearing loss, adult onset Alcohol use disorders Osteoarthritis Cerebrovascular disease Alzheimer and other dementias Asthma Rheumatoid arthritis Edentulism Source: PHAC, 2006 (in preparation) 0 50 000 100 000 150 000 200 000 250 000 300 000 350 000 Year-equivalents lost due to reduced functioning YLD of specified MSK conditions by sex, Canada 2003 Female Rheumatoid arthritis Osteoarthritis Gout Low back pain* Male Other musculoskeletal disorders 0 50 000 100 000 150 000 Source: PHAC, 2006 (in preparation) 7
$20 000 Top 10 Economic Burden of Illness in Canada, 2000 (in millions) $18 000 $16 000 $14 000 $12 000 $10 000 $8 000 $6 000 $4 000 $2 000 Musculoskeletal Diseases Diseases of the Circulatory System Neoplasms Injury and Poisonings Other, Unspecified Nervous System and Sense Organ Diseases Well-patient Care Mental Disorders Respiratory Diseases Digestive Diseases $0 Diagnostic Categories 8
Direct Cost of MSK by Cost Component, in Canada 2000 (in millions) 1 400,0 1 223,5 1 200,0 1 000,0 800,0 600,0 400,0 757,9 873,4 Hospitals Physicians Drugs Research Additional Direct 200,0 0,0 19,6 0 Based on a total of $2,874.3 Direct Cost of Specified MSK Conditions, Canada 2000 (in millions) Drugs Other Rheumatoid Arthritis Other Arthritis Physicians Osteoporosis Osteoarthritis Gout Hospitals Connective Tissue Disease $0 $100 $200 $300 $400 $500 9
Drug Cost for MSK by Age Group, Canada 2000 (in millions) $123,7 $0,0 $3,5 $93,4 74,0 $310,9 $167,8 0-14 15-34 35-54 55-64 65-74 75+ Unspecified Physician Cost for MSK by Age Group, Canada 2000 (in millions) $115,2 $0,1 $18,9 $118,2 10,9 $117,7 $277,0 0-14 15-34 35-54 55-64 65-74 75+ Unspecified 10
Hospital Cost for MSK by Age Group, Canada 2000 (in millions) $333,6 $7,3 $46,5 $129,7 $303,3 $234,2 $168,8 0-14 15-34 35-54 55-64 65-74 75+ Unspecified Total Direct Cost for MSK, from 1986 to 2000 Canada (in millions, 2000) $6 000 $5 000 $4 000 $3 000 Total Hospitals Physicians Drugs $2 000 $1 000 $0 1986 1993 1998 2000 11
Direct Cost for MKS, per capita, Canada 2000 $80.00 to $90.00 $90.00 to $100.00 $100.00 to $110.00 Total Indirect Cost for MSK by Component, Canada 2000 (in millions) $215 $311 $1 308 Mortality Long-term Morbidity Short-term Morbidity 12
Indirect Cost for MSK, from 1986 to 2000, Canada (in millions 2000) $40 000 $35 000 $30 000 $25 000 $20 000 $15 000 Total Long-term Morbidity Short-term Morbidity Mortality $10 000 $5 000 $0 1986 1993 1998 2000 Conclusion 13
Economic Impacts MSK account for 14% of the economic burden of illness in Canada, 2000; MSK s economic burden is now first before cardiovascular illnesses; MSK s indirect cost is six times the direct cost, in Canada; MSK s total cost is $700 per Canadian. Thank you! 14